GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
IL6 | 6018 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR and ELISA | NA | 0.48 | 0.0191 | 35116788
|
ABCA2 | 32 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SP assay followed by RT-PCR | NA | 0.2 | 0.0021 | 23226356
|
ABCC1 | 51 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SP assay followed by RT-PCR | NA | 0.2 | 0.0212 | 23226356
|
ABCG2 | 74 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.1739 | 35116788
|
ABCG2 | 74 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SP assay followed by RT-PCR | NA | 0.2 | 0.1739 | 23226356
|
CD44 | 1681 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR | NA | 0.2 | 1 | 35116788
|
CD44 | 1681 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | FACs followed by SFA | NA | 0.2 | 1 | 29340052
|
NANOG | 20857 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 35116788
|
POU5F1 | 9221 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 35116788
|
PROM1 | 9454 | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.7582 | 35116788
|
OV6 | NA | LTM | Bladder Cancer | Transitional Cell Papilloma | RT-4 | NA | SFA followed by FACs | NA | 0.12 | 0.0011 | 30397177
|